Daffodil Biosynth Profile
Key Indicators
- Authorised Capital ₹ 30.01 Cr
- Paid Up Capital ₹ 22.91 Cr
- Company Age 1 Year 3 Months
- Open Charges ₹ 21.00 Cr
About Daffodil Biosynth
Daffodil Biosynth Private Limited (DBPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 November 2023 (One year and three months 21 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 30.01 Cr and a paid-up capital of Rs 22.91 Cr.
The company currently has active open charges totaling ₹21.00 Cr.
Jitendra Patel, Kushal Patel, and Bhadreshkumar Patel serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U21001GJ2023PTC145994
- Company No.
145994
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Nov 2023
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Daffodil Biosynth?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jitendra Patel  | Director | 03-Nov-2023 | Current |
| Kushal Patel | Director | 03-Nov-2023 | Current |
| Bhadreshkumar Patel | Director | 21-May-2024 | Current |
Financial Performance of Daffodil Biosynth.
Enhance accessibility to Daffodil Biosynth's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Daffodil Biosynth?
Unlock access to Daffodil Biosynth's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Daffodil Pharmaceuticals Private LimitedJitendra Patel is a mutual person
- Daffodil Pharmachem Private Limited
Jitendra Patel and Kushal Patel are mutual person
Daffodil Biochem Private LimitedJitendra Patel and Kushal Patel are mutual person
- Daffocare Research Laboratory Llp
Kushal Patel is a mutual person
- Bridgecare F And D Private Limited
Kushal Patel is a mutual person
Charges (Loans)
₹21.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 21.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Nov 2024 | Hdfc Bank Limited | ₹21.00 Cr | Open |
How Many Employees Work at Daffodil Biosynth?
Unlock and access historical data on people associated with Daffodil Biosynth, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Daffodil Biosynth, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daffodil Biosynth's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.